Cargando…

TEPITOPEpan: Extending TEPITOPE for Peptide Binding Prediction Covering over 700 HLA-DR Molecules

MOTIVATION: Accurate identification of peptides binding to specific Major Histocompatibility Complex Class II (MHC-II) molecules is of great importance for elucidating the underlying mechanism of immune recognition, as well as for developing effective epitope-based vaccines and promising immunothera...

Descripción completa

Detalles Bibliográficos
Autores principales: Zhang, Lianming, Chen, Yiqing, Wong, Hau-San, Zhou, Shuigeng, Mamitsuka, Hiroshi, Zhu, Shanfeng
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Public Library of Science 2012
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3285624/
https://www.ncbi.nlm.nih.gov/pubmed/22383964
http://dx.doi.org/10.1371/journal.pone.0030483
_version_ 1782224494722547712
author Zhang, Lianming
Chen, Yiqing
Wong, Hau-San
Zhou, Shuigeng
Mamitsuka, Hiroshi
Zhu, Shanfeng
author_facet Zhang, Lianming
Chen, Yiqing
Wong, Hau-San
Zhou, Shuigeng
Mamitsuka, Hiroshi
Zhu, Shanfeng
author_sort Zhang, Lianming
collection PubMed
description MOTIVATION: Accurate identification of peptides binding to specific Major Histocompatibility Complex Class II (MHC-II) molecules is of great importance for elucidating the underlying mechanism of immune recognition, as well as for developing effective epitope-based vaccines and promising immunotherapies for many severe diseases. Due to extreme polymorphism of MHC-II alleles and the high cost of biochemical experiments, the development of computational methods for accurate prediction of binding peptides of MHC-II molecules, particularly for the ones with few or no experimental data, has become a topic of increasing interest. TEPITOPE is a well-used computational approach because of its good interpretability and relatively high performance. However, TEPITOPE can be applied to only 51 out of over 700 known HLA DR molecules. METHOD: We have developed a new method, called TEPITOPEpan, by extrapolating from the binding specificities of HLA DR molecules characterized by TEPITOPE to those uncharacterized. First, each HLA-DR binding pocket is represented by amino acid residues that have close contact with the corresponding peptide binding core residues. Then the pocket similarity between two HLA-DR molecules is calculated as the sequence similarity of the residues. Finally, for an uncharacterized HLA-DR molecule, the binding specificity of each pocket is computed as a weighted average in pocket binding specificities over HLA-DR molecules characterized by TEPITOPE. RESULT: The performance of TEPITOPEpan has been extensively evaluated using various data sets from different viewpoints: predicting MHC binding peptides, identifying HLA ligands and T-cell epitopes and recognizing binding cores. Among the four state-of-the-art competing pan-specific methods, for predicting binding specificities of unknown HLA-DR molecules, TEPITOPEpan was roughly the second best method next to NETMHCIIpan-2.0. Additionally, TEPITOPEpan achieved the best performance in recognizing binding cores. We further analyzed the motifs detected by TEPITOPEpan, examining the corresponding literature of immunology. Its online server and PSSMs therein are available at http://www.biokdd.fudan.edu.cn/Service/TEPITOPEpan/.
format Online
Article
Text
id pubmed-3285624
institution National Center for Biotechnology Information
language English
publishDate 2012
publisher Public Library of Science
record_format MEDLINE/PubMed
spelling pubmed-32856242012-03-01 TEPITOPEpan: Extending TEPITOPE for Peptide Binding Prediction Covering over 700 HLA-DR Molecules Zhang, Lianming Chen, Yiqing Wong, Hau-San Zhou, Shuigeng Mamitsuka, Hiroshi Zhu, Shanfeng PLoS One Research Article MOTIVATION: Accurate identification of peptides binding to specific Major Histocompatibility Complex Class II (MHC-II) molecules is of great importance for elucidating the underlying mechanism of immune recognition, as well as for developing effective epitope-based vaccines and promising immunotherapies for many severe diseases. Due to extreme polymorphism of MHC-II alleles and the high cost of biochemical experiments, the development of computational methods for accurate prediction of binding peptides of MHC-II molecules, particularly for the ones with few or no experimental data, has become a topic of increasing interest. TEPITOPE is a well-used computational approach because of its good interpretability and relatively high performance. However, TEPITOPE can be applied to only 51 out of over 700 known HLA DR molecules. METHOD: We have developed a new method, called TEPITOPEpan, by extrapolating from the binding specificities of HLA DR molecules characterized by TEPITOPE to those uncharacterized. First, each HLA-DR binding pocket is represented by amino acid residues that have close contact with the corresponding peptide binding core residues. Then the pocket similarity between two HLA-DR molecules is calculated as the sequence similarity of the residues. Finally, for an uncharacterized HLA-DR molecule, the binding specificity of each pocket is computed as a weighted average in pocket binding specificities over HLA-DR molecules characterized by TEPITOPE. RESULT: The performance of TEPITOPEpan has been extensively evaluated using various data sets from different viewpoints: predicting MHC binding peptides, identifying HLA ligands and T-cell epitopes and recognizing binding cores. Among the four state-of-the-art competing pan-specific methods, for predicting binding specificities of unknown HLA-DR molecules, TEPITOPEpan was roughly the second best method next to NETMHCIIpan-2.0. Additionally, TEPITOPEpan achieved the best performance in recognizing binding cores. We further analyzed the motifs detected by TEPITOPEpan, examining the corresponding literature of immunology. Its online server and PSSMs therein are available at http://www.biokdd.fudan.edu.cn/Service/TEPITOPEpan/. Public Library of Science 2012-02-23 /pmc/articles/PMC3285624/ /pubmed/22383964 http://dx.doi.org/10.1371/journal.pone.0030483 Text en Zhang et al. http://creativecommons.org/licenses/by/4.0/ This is an open-access article distributed under the terms of the Creative Commons Attribution License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original author and source are properly credited.
spellingShingle Research Article
Zhang, Lianming
Chen, Yiqing
Wong, Hau-San
Zhou, Shuigeng
Mamitsuka, Hiroshi
Zhu, Shanfeng
TEPITOPEpan: Extending TEPITOPE for Peptide Binding Prediction Covering over 700 HLA-DR Molecules
title TEPITOPEpan: Extending TEPITOPE for Peptide Binding Prediction Covering over 700 HLA-DR Molecules
title_full TEPITOPEpan: Extending TEPITOPE for Peptide Binding Prediction Covering over 700 HLA-DR Molecules
title_fullStr TEPITOPEpan: Extending TEPITOPE for Peptide Binding Prediction Covering over 700 HLA-DR Molecules
title_full_unstemmed TEPITOPEpan: Extending TEPITOPE for Peptide Binding Prediction Covering over 700 HLA-DR Molecules
title_short TEPITOPEpan: Extending TEPITOPE for Peptide Binding Prediction Covering over 700 HLA-DR Molecules
title_sort tepitopepan: extending tepitope for peptide binding prediction covering over 700 hla-dr molecules
topic Research Article
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3285624/
https://www.ncbi.nlm.nih.gov/pubmed/22383964
http://dx.doi.org/10.1371/journal.pone.0030483
work_keys_str_mv AT zhanglianming tepitopepanextendingtepitopeforpeptidebindingpredictioncoveringover700hladrmolecules
AT chenyiqing tepitopepanextendingtepitopeforpeptidebindingpredictioncoveringover700hladrmolecules
AT wonghausan tepitopepanextendingtepitopeforpeptidebindingpredictioncoveringover700hladrmolecules
AT zhoushuigeng tepitopepanextendingtepitopeforpeptidebindingpredictioncoveringover700hladrmolecules
AT mamitsukahiroshi tepitopepanextendingtepitopeforpeptidebindingpredictioncoveringover700hladrmolecules
AT zhushanfeng tepitopepanextendingtepitopeforpeptidebindingpredictioncoveringover700hladrmolecules